Playback speed
10 seconds
Alzheimer's Disease Research Highlights
By
Banner Alzheimer's Institute
FEATURING
Pierre Tariot
By
Banner Alzheimer's Institute
FEATURING
Pierre Tariot
475 views
July 10, 2024
Disclaimer: On July 2, 2024 the FDA approved Kisunla (donanemab-azbt) injection for the treatment of ...
read more ↘ Alzheimer’s disease. Treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was studied in the clinical trials.
↖ read less
read more ↘ Alzheimer’s disease. Treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was studied in the clinical trials.
↖ read less
Login to view comments.
Click here to Login